MedTrace Logo

Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

NCT02499185 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-15

No results posted yet for this study

Summary

To validate the use of \[TIMP-2\]●\[IGFBP-7\] to predict AKI in patients undergoing major intra abdominal surgery.

Conditions

Interventions

DEVICE

Nephro Check Test

Urine sample

OTHER

serum creatinine measurement

Blood sample

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Lien Torisaen, MD · Universitair Ziekenhuis Brussel

  • Jan Poelaert, Prof.Dr. · Universitair Ziekenhuis Brussel

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2017-07-31
Completion
2017-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02499185 on ClinicalTrials.gov